MITCHELLS+BUT. LS-,085416/ GB00B1FP6H53 /
| 2024-05-09 8:04:15 AM | Chg. +0.060 | Volume | Bid1:18:44 PM | Ask1:18:44 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.880EUR | +2.13% | 0 Turnover: 0.000 |
2.900Bid Size: 140 | 3.000Ask Size: 140 | 1.59 bill.EUR | - | - |
GlobeNewswire
1:45 PM
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp
1:30 PM
Cosa Resources Announces Summer Exploration Plans for Athabasca Basin Uranium Projects
GlobeNewswire
1:30 PM
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
1:30 PM
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire
1:30 PM
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
1:30 PM
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
1:30 PM
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire
1:30 PM
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
GlobeNewswire
1:30 PM
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
1:30 PM
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
GlobeNewswire
1:30 PM
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
1:30 PM
Eos Energy Enterprises Announces Participation in Upcoming Investor Conferences
GlobeNewswire
1:30 PM
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
1:30 PM
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024
GlobeNewswire
1:30 PM
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updat...
